Geneva Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-12,870
Closed -$499K 721
2015
Q1
$499K Buy
12,870
+570
+5% +$22.1K 0.01% 418
2014
Q4
$414K Buy
+12,300
New +$414K 0.01% 450